RAG launches lupus patient support group in Ahmedabad

The initiative by Rheumatology Association of Gujarat is aimed at strengthening patient-centric autoimmune care

WFNS opens doors to industry in landmark Neurosurgery Innovation Pact with Time Med

The move signals a strategic pivot toward deeper integration between clinical leadership and medical technology developers

Telangana life sciences ecosystem reaches $145 billion valuation

The state has received Rs. 84,000 crore investments in the sector over two years, positioning Hyderabad among the world’s leading life sciences clusters

Imfinzi-based regimens deliver major survival gains in muscle-invasive bladder cancer

The study has shown that perioperative treatment with Imfinzi (durvalumab), alone or in combination with other immunotherapy agents

Edwards Lifesciences highlights 10-year data reinforcing durability of RESILIA tissue

Pfizer scores landmark EU approval for hemophilia drug HYMPAVZI

The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy

Revvity wins FDA clearance for total testosterone test

Roche wins CE mark for Alzheimer’s blood test that could transform early diagnosis

The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline

Breakthrough wearable heart failure therapy enables earlier hospital discharge: UK trial

Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care

Actio Biosciences launches Phase 1b/2 trial for ultra-rare pediatric epilepsy therapy

The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process